Sanofi-Aventis’ new benchmark to be its tightest yet
Sanofi-Aventis has set guidance for its second benchmark of the year, a five and ten year dual tranche issue, at far tighter levels than it attained for its four and seven year trade in May. To find out how it fares, along with all the other deals in the market this week fared, read EuroWeek on Friday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts